These results suggest that elevated RDH16 expression is commonly associated with reduced TGFB1 levels, implying that RDH16 upregulation may suppress immune evasion in the HCC tumor microenvironment by alleviating TGFB1-mediated immunosuppression (Figure 8E). This evidence concerns the gene RDH16 and neoplasm.